O Chosidow

Summary

Country: France

Publications

  1. ncbi [Systemic corticosteroids]
    O Chosidow
    , , , 4, rue de la Chine, 75020 Paris
    Ann Dermatol Venereol 134:942-8. 2007
  2. ncbi Clinical practices. Scabies
    Olivier Chosidow
    , Paris 6
    N Engl J Med 354:1718-27. 2006
  3. ncbi Treatment to prevent recurrent genital herpes
    Valerie Martinez
    Université Denis Diderot Paris VII and Service des Maladies Infectieuses et Tropicales, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, France
    Curr Opin Infect Dis 21:42-8. 2008
  4. ncbi Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient
    Stephane Barete
    Department of Dermatology and Allergy, Hopital Tenon, Assistance Publique Hopitaux de Paris, France
    Emerg Infect Dis 13:736-8. 2007
  5. ncbi A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks
    Bénédicte Lebrun-Vignes
    Department of Pharmacology, Hopital Pitie Salpetriere, Paris, France
    J Am Acad Dermatol 57:238-46. 2007
  6. ncbi Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases
    Vincent Descamps
    Department of Dermatology, Bichat Claude Bernard Hospital, Paris, France
    Dermatology 217:81-4. 2008
  7. ncbi Prediction of survival for patients with bullous pemphigoid: a prospective study
    Pascal Joly
    Department of Dermatology, Institut National de la Santé et de la Récherche Médicale U 519, University of Rouen, Rouen, France
    Arch Dermatol 141:691-8. 2005
  8. ncbi Ivermectin in dermatology
    Pascal Del Giudice
    Unité Infectiologie Dermatologie, Hôpital Bonnet 83600, Frejus, France
    J Drugs Dermatol 2:13-21. 2003
  9. ncbi Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides
    Pierre Wolkenstein
    J Invest Dermatol 125:1080-2. 2005
  10. ncbi [Cutaneous infections in the homeless]
    Sophie Consigny
    , , 75004 Paris
    Rev Prat 53:1977-81. 2003

Detail Information

Publications16

  1. ncbi [Systemic corticosteroids]
    O Chosidow
    , , , 4, rue de la Chine, 75020 Paris
    Ann Dermatol Venereol 134:942-8. 2007
  2. ncbi Clinical practices. Scabies
    Olivier Chosidow
    , Paris 6
    N Engl J Med 354:1718-27. 2006
  3. ncbi Treatment to prevent recurrent genital herpes
    Valerie Martinez
    Université Denis Diderot Paris VII and Service des Maladies Infectieuses et Tropicales, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, France
    Curr Opin Infect Dis 21:42-8. 2008
    ..Recurrent genital herpes is associated with major medical and psychosocial morbidities; therefore, suppressive therapy is required, especially in patients with frequent and/or severe episodes...
  4. ncbi Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient
    Stephane Barete
    Department of Dermatology and Allergy, Hopital Tenon, Assistance Publique Hopitaux de Paris, France
    Emerg Infect Dis 13:736-8. 2007
    ..The diagnosis was based on skin histopathologic results and confirmed by isolation of the ameba from involved skin and molecular analysis of a partial 18S rRNA gene sequence (DF3)...
  5. ncbi A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks
    Bénédicte Lebrun-Vignes
    Department of Pharmacology, Hopital Pitie Salpetriere, Paris, France
    J Am Acad Dermatol 57:238-46. 2007
    ..Efficacy of oral antiviral therapies, ie, acyclovir, valacyclovir (VACV), and famciclovir, for suppression of recurrent genital herpes was studied at different doses and regimens...
  6. ncbi Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases
    Vincent Descamps
    Department of Dermatology, Bichat Claude Bernard Hospital, Paris, France
    Dermatology 217:81-4. 2008
    ..Cosmetic filler injections are now a very common procedure for aesthetic purposes. Today no contra-indication is given anymore to any patient for an intradermal filling...
  7. ncbi Prediction of survival for patients with bullous pemphigoid: a prospective study
    Pascal Joly
    Department of Dermatology, Institut National de la Santé et de la Récherche Médicale U 519, University of Rouen, Rouen, France
    Arch Dermatol 141:691-8. 2005
    ..To identify the prognostic factors of bullous pemphigoid (BP)...
  8. ncbi Ivermectin in dermatology
    Pascal Del Giudice
    Unité Infectiologie Dermatologie, Hôpital Bonnet 83600, Frejus, France
    J Drugs Dermatol 2:13-21. 2003
    ..In this paper we review parasitoses which have been treated with ivermectin; mainly, filariasis, strongyloidiasis, cutaneous larva migrans, and scabies and head lice...
  9. ncbi Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides
    Pierre Wolkenstein
    J Invest Dermatol 125:1080-2. 2005
  10. ncbi [Cutaneous infections in the homeless]
    Sophie Consigny
    , , 75004 Paris
    Rev Prat 53:1977-81. 2003
  11. ncbi Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient
    Sophie Consigny
    Department of Internal Medicine, , , Paris, France
    Clin Infect Dis 37:311-3. 2003
    ..Voriconazole might be an alternative therapy for patients with neutropenia who have fusariosis that is refractory or unresponsive to amphotericin B or its liposomal formulation...
  12. ncbi Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study
    Arnold P Oranje
    Department of Dermatology and Venereology Pediatric Dermatology, University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
    Dermatology 215:331-40. 2007
    ..Retapamulin is a novel pleuromutilin antibacterial developed for topical use...
  13. ncbi Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials
    Laurence Le Cleach
    Service de Dermatologie, Centre Hospitalier Sud Francilien, Corbeil Essonnes, France
    Dermatology 216:46-55. 2008
    ..Because many dermatological diseases are chronic but not life-threatening, consideration of their impact on health-related quality of life (QOL) seems essential...
  14. ncbi Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial
    Philippe Bernard
    Department of Dermatology, Hopital Robert Debre, 51092 Reims, France
    BMJ 325:864. 2002
    ..To assess the efficacy and safety of oral pristinamycin versus intravenous then oral penicillin to treat erysipelas in patients in hospital...
  15. ncbi Erythema ab igne as an unexpected computer side-effect
    Elie Maalouf
    Dermatology 212:392-3. 2006